… With the objective of linking early findings relating to the novel SARS-CoV-2 coronavirus …
therapeutic response, a coherent cellular and molecular pathway is proposed for COVID-19. …

… Noted to have inhibitory activity against SARS and the Middle East respiratory syndrome (MERS),(1,
4, 14, 18, 20) was identified early as a promising therapeutic candidate for Covid-19 …

… some therapeutic interventions may be beneficial to specific subgroups of COVID-19 patients,
… Future systematic reviews on COVID-19 treatments should adhere to the recommended …

… As there is a huge volume of therapeutic approaches for COVID-19, we may not cover all
available therapeutic approaches. In addition, research results are dynamic and change as …

… COVID-19 is an infectious respiratory disease … therapeutic targets and strategies, both
conventional and alternative, along with vaccine candidates in clinical trials against COVID-19. …

… the treatment and management of COVID-19, albeit others … therapeutic drugs being
repurposed or used in the clinical trials and discussed their clinical efficacy and safety for COVID-19…

… monoclonal antibody based therapeutic intervention for COVID-19 by considering the existing
… Further research on COVID-19 pathogenesis could identify appropriate therapeutic targets …

… a long list of therapeutic candidates for COVID-19 with near-term potential. The goals have
been to prioritize and test potential therapeutic agents for COVID-19 that have already been …

… -19. Here, we discuss the major inflammatory pathways in the pathogenesis of COVID-19, …
, as well as existing and potential interventions targeting these cytokines or related signaling …

… This was further confirmed by results from the large Randomized Evaluation of COVID-19
Therapy (RECOVERY) trial that examined 1,542 hospitalized COVID-19 patients treated with …